Royal United Hospitals Bath Stroke Drug Trials
“`html
RUH Bath launches Study to Improve Quality of Life for Stroke Survivors
Table of Contents
A new clinical trial at the Royal United Hospital (RUH) bath aims to assess the potential of existing drugs to improve the lives of individuals who have experienced a lacunar stroke, a common but frequently enough debilitating condition.
Published November 2, 2023
Understanding Lacunar Strokes and the Study
The study, open to patients aged 30 and above, focuses on those who have suffered a lacunar ischemic stroke - a stroke affecting the small blood vessels in the brain. Participants must not have any other active neurological diseases to qualify, according to a statement from RUH Bath. Lacunar strokes are a meaningful health concern, accounting for approximately 20% of all ischemic strokes according to the American Stroke Association.
Ms. Stoney, whose full name and title were not provided in the source material, emphasized the impact of these strokes. “A lacunar stroke is quite common, but can still have very serious consequences for people, particularly the way it can affect people’s thinking, balance and walking,” she said.
Currently, ther are no specific treatments available for small vessel disease, the underlying cause of lacunar strokes. This study will investigate whether drugs already approved for other conditions can offer benefits to stroke survivors. The trial will involve approximately 18 months of participation, with patient progress monitored through regular phone calls.
Potential Impact and Call for Volunteers
Researchers hope the study will lead to a tangible improvement in the “quality of life” for stroke survivors. This encompasses physical, emotional, and cognitive well-being, areas often significantly impacted by lacunar strokes. The study also aims to identify potential treatments for future patients.
Ms. Stoney urged anyone who might be eligible to participate. ”I would appeal to anyone who coudl be part of the trial to get in touch and find out more – you will be playing a vital role in shaping the future of treatment for stroke patients,” she added.
More About Stroke and Small Vessel Disease
Stroke is a leading cause of long-term disability and death worldwide. According to the Centers for Disease Control and Prevention (CDC), someone in the United States has a stroke every 40 seconds. Small vessel disease, frequently enough linked to conditions like hypertension and diabetes, is a major contributor to stroke risk.
Early detection and management of risk factors, such as high blood pressure, high cholesterol, and smoking, are crucial for preventing strokes. Lifestyle modifications, including a healthy diet and regular exercise, can also play a significant role in reducing stroke risk. For more facts on stroke prevention and treatment, visit the American Stroke Association website.
